explore -WSS

explore

author：leisure time 2025-09-05 05:51:55 - browse：29273

An artist's rendering of the building — currently under construction along Boston's Fort Point Channel — where Eli Lilly plans to open its Institute for Genetic Medicine. Courtesy Alexandria Real Estate Equities Inc

Eli Lilly and Co., which transformed itself from a stodgy underperformer into one of the world’s hottest pharmaceutical companies, said this week that the genetic medicine research center it plans to open in Boston in August will eventually employ twice as many workers as originally estimated.

In February 2022, Lilly said that it would increase its modest Massachusetts workforce from 120 to 250 employees when it opened the $700 million Lilly Institute for Genetic Medicine along Fort Point Channel. The Indianapolis-based company said it would move 120 scientists from Kendall Square in Cambridge to the institute and add another 130.

But Daniel Skovronsky, Lilly’s chief scientific and medical officer, said in an interview that the 12-story, 334,000-square-foot laboratory and office building will ultimately accommodate 500 Lilly scientists and researchers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Doctors find melanoma drugs effective against rare brain cancer

hotspot

WSS

Listen: Wegovy in the brain & pivotal Alzheimer's data

Google and Epic fight stronger regulation of AI in health care

How Medicaid coverage policies for immigrants impact new moms

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Oak Street deal isn't the answer to health care's woes

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

explore

explore

focus

Psychedelics group wrestles with new pharma identity

Medicare has a new plan to address drug shortages

After affirmative action ruling, medical educators look to 'holistic review'

A public scorecard can help hold safety

Continuity nursing helped my family in our darkest PICU moments

Free medical tuition alone isn't enough to close gaps in primary care

FDA approval of Sarepta Duchenne genetic therapy gives me hope

WuXi Biologics beefs up its lobbying operation

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

At Orexo, a ‘turning point’ for everything but digital health

knowledge

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Sanders adds drug shortage policies to pandemic preparedness bill

How Medicaid coverage policies for immigrants impact new moms

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

In early work, researchers turn to CRISPR to treat Alzheimer's

focus

explore

hotspot

entertainment